Skip to main content
logo
Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0531
-0.0069 (-11.50%)
Sep 8, 2026, 3:54 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
222350404523
Market Cap Growth
-29.20%-53.45%25.33%-11.35%96.93%-1.55%
Enterprise Value
252653434823
Last Close Price
0.050.060.120.100.110.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-69.9081.7972.2145.94-
PB Ratio
-3.55-3.73-8.46-5.30-7.29-5.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-76.9486.0577.2548.64-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.56-0.47-0.53-0.40-0.35-0.42
Net Debt / Equity Ratio
-0.37-0.43-0.48-0.39-0.35-0.25
Net Debt / EBITDA Ratio
-0.57-0.56-0.73-1.18-0.76-0.23
Net Debt / FCF Ratio
-0.97-0.82-0.88-1.15-0.71-1.05
Asset Turnover
-0.400.500.320.36-
Quick Ratio
0.150.040.040.010.000.09
Current Ratio
0.180.080.140.150.230.45
Return on Assets (ROA)
-236.54%-355.41%-200.92%-89.58%-64.62%-141.40%
Return on Capital Employed (ROCE)
66.70%78.10%66.10%33.00%46.60%110.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.28%-23.12%-9.38%-7.70%-7.82%-24.01%
FCF Yield
-10.87%-14.16%-6.51%-6.39%-6.69%-4.39%
Buyback Yield / Dilution
-0.02%-0.11%-0.07%-0.01%-2.76%-3.81%